About Us

European Alliance for Transformative Therapies (TRANSFORM)

The European Alliance for Transformative Therapies (TRANSFORM) is a multi-stakeholder Alliance that connects Members of the European Parliament (MEPs) and policy-makers with patient groups, medical experts and associations, scientists, researchers, industry actors, networks and other relevant stakeholders. TRANSFORM aims to foster effective dialogue and provide evidence-based policy recommendations to enable safe and timely patient access to cell and gene therapies, whilst ensuring the sustainability of healthcare systems. 

Our Objectives

TRANSFORM aims to facilitate discussions between stakeholders and policy-makers, with the following objectives:

  • Collaborate in the development and dissemination of evidence-based recommendations to enable patient access to cell and gene therapies.
  • Inform MEPs about the specificities of these transformative therapies with a view to shaping policy.
  • Prepare healthcare systems for the adoption of these transformative therapies.

Structure

The European Alliance for Transformative Therapies is a multi-stakeholder coalition open to any stakeholders active in the field of transformative therapies. A Steering Group with a balanced representation of the members facilitates the work of the Alliance.

The TRANSFORM MEP Interest Group comprises cross-party Members of the European Parliament. Three Co-Chairs lead the initiative and pursue dialogue with stakeholders and decision-makers.

The TRANSFORM Secretariat provides organisational support to both the European Alliance for Transformative Therapies and the TRANSFORM MEP Interest Group. Its work is enabled by funding from the European Confederation of Pharmaceutical Entrepreneurs (EUCOPE) and its members.

@TRANSFORM_CGT on Twitter Follow us →

The report on the @TRANSFORM_CGT MEP Interest Group event on cross-border access to #ATMPs is now available! Read the key takeaways & 5 Policy Asks launched by MEPs to support timely and equitable access to #ATMPs for all 🇪🇺 patients. 👉 https://t.co/k6Zhog5oii #MEPsforATMPs https://t.co/f2Qxd3xdhQ
26 November at 2:47pm
With Ask #5, TRANSFORM MEPs call on the EU to use EU4Health funds to minimize the burden on families, covering costs of travelling and stay in the country of treatment. #MEPsforATMPs 👉https://t.co/B0qdhY0ijY https://t.co/irwB8ywH3A
26 November at 10:29am
RT @eurordis: Yesterday was a rare opportunity to watch 19 MEPs debate the EU’s approach to rare diseases, to highlight the urgency and rel…
25 November at 2:51pm